…owed positive results in phase 3 trials and was approved in the US in 2025 for idiopathic pulmonary fibrosis and progressive pulmo…
4articles mentioning institutions
5institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: US ×
US
This institution is selected. Its supporting articles are shown below.
Articles mentioning US
4 articles · page 1 of 1USpulmonary fibrosispirfenidonenintedanibnerandomilast
US
…The US has launched a multimillion dollar five year campaign to measur…
Joshua J SkydelUSbiosimilars
…Tiffany E Jiang, Reshma Ramachandran, and Joshua J Skydel argue that US requirements for interchangeability are not suppo…